Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Correspondence for "clinical epidemiology of familial sarcoidosis: A systematic literature review".

Calender A, Valeyre D, Israel-Biet D, Pacheco Y.

Respir Med. 2019 Jun 10. pii: S0954-6111(19)30183-0. doi: 10.1016/j.rmed.2019.06.002. [Epub ahead of print] No abstract available.

PMID:
31202573
2.

Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis.

Calender A, Lim CX, Weichhart T, Buisson A, Besnard V, Rollat-Farnier PA, Bardel C, Roy P, Cottin V, Devouassoux G, Finat A, Pinson S, Lebecque S, Nunes H, Israel-Biet D, Bentaher A, Valeyre D, Pacheco Y; in the frame of GSF (Group Sarcoidosis France).

Eur Respir J. 2019 Aug 1;54(2). pii: 1900430. doi: 10.1183/13993003.00430-2019. Print 2019 Aug. No abstract available.

PMID:
31023854
3.

A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT.

Jouneau S, Gamez AS, Traclet J, Nunes H, Marchand-Adam S, Kessler R, Israël-Biet D, Borie R, Strombom I, Scalori A, Crestani B, Valeyre D, Cottin V.

Respiration. 2019;98(1):19-28. doi: 10.1159/000496735. Epub 2019 Apr 9.

PMID:
30965332
4.

Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity.

Blandinières A, Gendron N, Bacha N, Bièche I, Chocron R, Nunes H, Nevo N, Rossi E, Crestani B, Lecourt S, Chevret S, Lokajczyk A, Mignon V, Kisaoglu A, Juvin K, Bertil S, Valeyre D, Cras A, Gaussem P, Israël-Biet D, Smadja DM.

Angiogenesis. 2019 May;22(2):325-339. doi: 10.1007/s10456-018-09659-5. Epub 2019 Jan 3.

PMID:
30607696
5.

Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension.

Bacha NC, Levy M, Guerin CL, Le Bonniec B, Harroche A, Szezepanski I, Renard JM, Gaussem P, Israel-Biet D, Boulanger CM, Smadja DM.

Pediatr Pulmonol. 2019 Jan;54(1):66-72. doi: 10.1002/ppul.24190. Epub 2018 Nov 28.

PMID:
30485728
6.

[Pulmonary fibrosis associated with hereditary fibrosing poikiloderma caused by FAM111B mutation: A case report].

Sanchis-Borja M, Pastré J, Mercier S, Juvin K, Benattia A, Israël-Biet D.

Rev Mal Respir. 2018 Nov;35(9):968-973. doi: 10.1016/j.rmr.2018.09.002. Epub 2018 Oct 16. French.

PMID:
30341002
7.

Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice.

Blandinières A, Gille T, Sadoine J, Bièche I, Slimani L, Dizier B, Gaussem P, Chaussain C, Planes C, Dorfmüller P, Israël-Biet D, Smadja DM.

Stem Cell Rev Rep. 2018 Dec;14(6):812-822. doi: 10.1007/s12015-018-9846-5.

PMID:
30267203
8.

Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.

Leroy S, Benzaquen J, Mazzetta A, Marchand-Adam S, Padovani B, Israel-Biet D, Pison C, Chanez P, Cadranel J, Mazières J, Jounieaux V, Cohen C, Hofman V, Ilie M, Hofman P, Marquette CH; AIR Project Study Group.

BMJ Open. 2017 Dec 26;7(12):e018884. doi: 10.1136/bmjopen-2017-018884.

9.

Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis.

Bacha NC, Blandinieres A, Rossi E, Gendron N, Nevo N, Lecourt S, Guerin CL, Renard JM, Gaussem P, Angles-Cano E, Boulanger CM, Israel-Biet D, Smadja DM.

Stem Cell Rev Rep. 2018 Apr;14(2):223-235. doi: 10.1007/s12015-017-9778-5.

PMID:
29101610
10.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. 2017 update. Full-length update].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 21. pii: S0761-8425(17)30209-7. doi: 10.1016/j.rmr.2017.07.018. [Epub ahead of print] French. No abstract available.

11.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Full-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):900-968. doi: 10.1016/j.rmr.2017.07.017. Epub 2017 Sep 20. No abstract available.

PMID:
28939155
12.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Short-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):852-899. doi: 10.1016/j.rmr.2017.07.019. Epub 2017 Sep 20. No abstract available.

PMID:
28939154
13.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Short-length version].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 18. pii: S0761-8425(17)30211-5. doi: 10.1016/j.rmr.2017.07.020. [Epub ahead of print] French. No abstract available.

PMID:
28935497
14.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 19. pii: S0761-8425(17)30212-7. doi: 10.1016/j.rmr.2017.07.021. [Epub ahead of print] French. No abstract available.

PMID:
28935496
15.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):834-851. doi: 10.1016/j.rmr.2017.07.022. Epub 2017 Sep 19. No abstract available.

PMID:
28935495
16.

Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis.

Sesé L, Nunes H, Cottin V, Sanyal S, Didier M, Carton Z, Israel-Biet D, Crestani B, Cadranel J, Wallaert B, Tazi A, Maître B, Prévot G, Marchand-Adam S, Guillot-Dudoret S, Nardi A, Dury S, Giraud V, Gondouin A, Juvin K, Borie R, Wislez M, Valeyre D, Annesi-Maesano I.

Thorax. 2018 Feb;73(2):145-150. doi: 10.1136/thoraxjnl-2017-209967. Epub 2017 Aug 10.

PMID:
28798214
17.

Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis.

Gille T, Didier M, Boubaya M, Moya L, Sutton A, Carton Z, Baran-Marszak F, Sadoun-Danino D, Israël-Biet D, Cottin V, Gagnadoux F, Crestani B, d'Ortho MP, Brillet PY, Valeyre D, Nunes H, Planès C; collaborators.

Eur Respir J. 2017 Jun 8;49(6). pii: 1601934. doi: 10.1183/13993003.01934-2016. Print 2017 Jun.

18.

In smokers, Sonic hedgehog modulates pulmonary endothelial function through vascular endothelial growth factor.

Henno P, Grassin-Delyle S, Belle E, Brollo M, Naline E, Sage E, Devillier P, Israël-Biet D.

Respir Res. 2017 May 23;18(1):102. doi: 10.1186/s12931-017-0590-1.

19.

Very Small Embryonic-like Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension.

Guerin CL, Blandinières A, Planquette B, Silvestre JS, Israel-Biet D, Sanchez O, Smadja DM.

Stem Cell Rev Rep. 2017 Aug;13(4):561-566. doi: 10.1007/s12015-017-9732-6.

PMID:
28285391
20.

Pulmonary benign metastasizing leiomyoma presented as acute respiratory distress.

Pastré J, Juvin K, Grand B, Gibault L, Valcke J, Israël-Biet D.

Respirol Case Rep. 2017 Jan 19;5(2):e00216. doi: 10.1002/rcr2.216. eCollection 2017 Mar.

21.

Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.

Pacheco Y, Calender A, Israël-Biet D, Roy P, Lebecque S, Cottin V, Bouvry D, Nunes H, Sève P, Pérard L, Devouassoux G, Freymond N, Khouatra C, Wallaert B, Lamy R, Elsensohn MH, Bardel C, Valeyre D; GSF group.

Orphanet J Rare Dis. 2016 Dec 3;11(1):165.

22.

Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis.

Borie R, Tabèze L, Thabut G, Nunes H, Cottin V, Marchand-Adam S, Prevot G, Tazi A, Cadranel J, Mal H, Wemeau-Stervinou L, Bergeron Lafaurie A, Israel-Biet D, Picard C, Reynaud Gaubert M, Jouneau S, Naccache JM, Mankikian J, Ménard C, Cordier JF, Valeyre D, Reocreux M, Grandchamp B, Revy P, Kannengiesser C, Crestani B.

Eur Respir J. 2016 Dec;48(6):1721-1731. doi: 10.1183/13993003.02115-2015. Epub 2016 Nov 11.

23.

Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey.

Cottin V, Bergot E, Bourdin A, Cadranel J, Camus P, Crestani B, Dalphin JC, Delaval P, Dromer C, Israel-Biet D, Kessler R, Marchand-Adam S, Marquette CH, Prévot G, Reynaud-Gaubert M, Valeyre D, Wallaert B, Bouquillon B, Cordier JF.

ERJ Open Res. 2015 Nov 16;1(2). pii: 00032-2015. eCollection 2015 Oct.

24.

[Diffuse interstitial lung disease: What is the role of bronchoalveolar lavage?].

Israël-Biet D, Pastré J, Juvin K.

Rev Prat. 2015 Dec;65(10):1312-5. French.

PMID:
26979030
25.

Increased volume of conducting airways in idiopathic pulmonary fibrosis is independent of disease severity: a volumetric capnography study.

Plantier L, Debray MP, Estellat C, Flamant M, Roy C, Bancal C, Borie R, Israël-Biet D, Mal H, Crestani B, Delclaux C.

J Breath Res. 2016 Feb 1;10(1):016005. doi: 10.1088/1752-7155/10/1/016005.

PMID:
26828240
26.

Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations.

Mercier S, Küry S, Salort-Campana E, Magot A, Agbim U, Besnard T, Bodak N, Bou-Hanna C, Bréhéret F, Brunelle P, Caillon F, Chabrol B, Cormier-Daire V, David A, Eymard B, Faivre L, Figarella-Branger D, Fleurence E, Ganapathi M, Gherardi R, Goldenberg A, Hamel A, Igual J, Irvine AD, Israël-Biet D, Kannengiesser C, Laboisse C, Le Caignec C, Mahé JY, Mallet S, MacGowan S, McAleer MA, McLean I, Méni C, Munnich A, Mussini JM, Nagy PL, Odel J, O'Regan GM, Péréon Y, Perrier J, Piard J, Puzenat E, Sampson JB, Smith F, Soufir N, Tanji K, Thauvin C, Ulane C, Watson RM, Khumalo NP, Mayosi BM, Barbarot S, Bézieau S.

Orphanet J Rare Dis. 2015 Oct 15;10:135. doi: 10.1186/s13023-015-0352-4.

27.

Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases.

Pastre J, Plantier L, Planes C, Borie R, Nunes H, Delclaux C, Israël-Biet D.

BMC Pulm Med. 2015 Sep 3;15:100. doi: 10.1186/s12890-015-0084-1.

28.

Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells.

Smadja DM, Levy M, Huang L, Rossi E, Blandinières A, Israel-Biet D, Gaussem P, Bischoff J.

Thromb Haemost. 2015 Oct;114(4):735-47. doi: 10.1160/TH14-11-0907. Epub 2015 Jun 11.

29.

Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?

Henno P, Maurey C, Le Pimpec-Barthes F, Devillier P, Delclaux C, Israël-Biet D.

Respir Res. 2015 Mar 28;16:46. doi: 10.1186/s12931-015-0196-4.

30.

Interstitial lung disease in anti-synthetase syndrome: initial and follow-up CT findings.

Debray MP, Borie R, Revel MP, Naccache JM, Khalil A, Toper C, Israel-Biet D, Estellat C, Brillet PY.

Eur J Radiol. 2015 Mar;84(3):516-523. doi: 10.1016/j.ejrad.2014.11.026. Epub 2014 Dec 3.

PMID:
25541020
31.

[Pleural effusion: diagnosis and management].

Pastré J, Roussel S, Israël Biet D, Sanchez O.

Rev Med Interne. 2015 Apr;36(4):248-55. doi: 10.1016/j.revmed.2014.10.360. Epub 2014 Nov 29. Review. French.

PMID:
25438932
32.

Increase in both angiogenic and angiostatic mediators in patients with idiopathic pulmonary fibrosis.

Smadja DM, Nunes H, Juvin K, Bertil S, Valeyre D, Gaussem P, Israel-Biet D.

Pathol Biol (Paris). 2014 Dec;62(6):391-4. doi: 10.1016/j.patbio.2014.07.006. Epub 2014 Sep 16.

PMID:
25239280
33.

Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway.

Smadja DM, Dorfmüller P, Guerin CL, Bieche I, Badoual C, Boscolo E, Kambouchner M, Cazes A, Mercier O, Humbert M, Gaussem P, Bischoff J, Israël-Biet D.

Thromb Haemost. 2014 Nov;112(5):1002-13. doi: 10.1160/TH13-08-0711. Epub 2014 Aug 7.

34.

Lack of correlation of BTNL2 polymorphism and cancer risk in sarcoidosis. BTNL2 and cancer risk in sarcoidosis.

Gaillot-Drevon M, Calender A, Blay JY, Valeyre D, Israel-Biet D, Roy P, Pacheco Y.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Jul 8;31(2):136-41.

PMID:
25078641
35.

Phenotypically aberrant clonal T cells in the lungs of patients with type II refractory celiac disease.

Pastré J, Juvin K, Malamut G, Derrieux C, Cellier C, Israël-Biet D.

Blood. 2014 Jun 5;123(23):3674-5. doi: 10.1182/blood-2014-04-566513. No abstract available.

PMID:
24904104
36.

Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines.

Cottin V, Crestani B, Valeyre D, Wallaert B, Cadranel J, Dalphin JC, Delaval P, Israel-Biet D, Kessler R, Reynaud-Gaubert M, Aguilaniu B, Bouquillon B, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Kouzan S, Lebargy F, Marchand-Adam S, Philippe B, Prévot G, Stach B, Thivolet-Béjui F, Cordier JF; French National Reference Centre; Network of Competence Centres for Rare Lung Diseases.

Eur Respir Rev. 2014 Jun;23(132):193-214. doi: 10.1183/09059180.00001814. Review.

37.

[Idiopathic pulmonary fibrosis: diagnosis and treatment in 2013].

Israël-Biet D, Juvin K, Dang Tran K, Badia A, Cazes A, Delclaux C.

Rev Pneumol Clin. 2014 Feb-Apr;70(1-2):108-17. doi: 10.1016/j.pneumo.2013.12.004. Epub 2014 Feb 22. Review. French.

PMID:
24566024
38.

Management of idiopathic pulmonary fibrosis in France: a survey of 1244 pulmonologists.

Cottin V, Cadranel J, Crestani B, Dalphin JC, Delaval P, Israel-Biet D, Kessler R, Reynaud-Gaubert M, Valeyre D, Wallaert B, Bouquillon B, Cordier JF.

Respir Med. 2014 Jan;108(1):195-202. doi: 10.1016/j.rmed.2013.11.017. Epub 2013 Dec 3.

39.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. From the National Reference and the Competence centers for rare diseases and the Société de Pneumologie de Langue Française].

Cottin V, Crestani B, Valeyre D, Wallaert B, Cadranel J, Dalphin JC, Delaval P, Israel-Biet D, Kessler R, Reynaud-Gaubert M, Cordier JF, Aguilaniu B, Bouquillon B, Carré P, Danel C, Faivre JB, Ferreti G, Just N, Kouzan S, Lebargy F, Marchand Adam S, Philippe B, Prévot G, Stach B, Thivolet-Béjui F; French National Reference and Competence Centers for Rare Diseases; Societe de Pneumologies de Langue Francaise.

Rev Mal Respir. 2013 Dec;30(10):879-902. doi: 10.1016/j.rmr.2013.09.007. Epub 2013 Oct 25. French. No abstract available. Erratum in: Rev Mal Respir. 2014 Feb;31(2):194-5.

40.

Outcome of patients with interstitial lung disease admitted to the intensive care unit.

Vial-Dupuy A, Sanchez O, Douvry B, Guetta L, Juvin K, Wermert D, Guérot E, Israël-Biet D.

Sarcoidosis Vasc Diffuse Lung Dis. 2013 Aug 1;30(2):134-42.

PMID:
24071885
41.

Cross-sectional assessment of the relationships between dyspnea domains and lung function in diffuse parenchymal lung disease.

Londner C, Al Dandachi G, Plantier L, Gillet-Juvin K, Chevalier-Bidaud B, Mahut B, Israel-Biet D, Delclaux C.

Respiration. 2014;87(2):105-12. doi: 10.1159/000351110. Epub 2013 Aug 27.

42.

The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.

Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, Airo P, Matucci-Cerinic M, Wallaert B, Israel-Biet D, Cadranel J, Cottin V, Gazal S, Peljto AL, Varga J, Schwartz DA, Valeyre D, Grandchamp B.

PLoS One. 2013 Aug 5;8(8):e70621. doi: 10.1371/journal.pone.0070621. Print 2013. Review.

43.

Diagnosis of pulmonary sarcoidosis.

Israel-Biet D, Valeyre D.

Curr Opin Pulm Med. 2013 Sep;19(5):510-5. doi: 10.1097/MCP.0b013e3283645950. Review.

PMID:
23880701
44.

Response to commentary: 'If roflumilast inhibits the innate immunity in the stable patient, what about infection?'.

Buenestado A, Grassin-Delyle S, Guitard F, Naline E, Faisy C, Israël-Biet D, Sage E, Bellamy JF, Tenor H, Devillier P.

Clin Respir J. 2013 Jul;7(3):e20-1. doi: 10.1111/crj.12019. Epub 2013 Jun 13. No abstract available.

PMID:
23763715
45.

Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis.

Smadja DM, Mauge L, Nunes H, d'Audigier C, Juvin K, Borie R, Carton Z, Bertil S, Blanchard A, Crestani B, Valeyre D, Gaussem P, Israel-Biet D.

Angiogenesis. 2013 Jan;16(1):147-57. doi: 10.1007/s10456-012-9306-9. Epub 2012 Sep 16.

PMID:
22983452
46.

Serial computed tomography and lung function testing in pulmonary Langerhans' cell histiocytosis.

Tazi A, Marc K, Dominique S, de Bazelaire C, Crestani B, Chinet T, Israel-Biet D, Cadranel J, Frija J, Lorillon G, Valeyre D, Chevret S.

Eur Respir J. 2012 Oct;40(4):905-12. Epub 2012 Mar 22.

47.

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study.

Crestani B, Chapron J, Wallaert B, Bergot E, Delaval P, Israel-Biet D, Lacronique J, Monnet I, Reynaud-Gaubert M, Tazi A, Lebtahi R, Debray MP, Brauner M, Dehoux M, Dornic Q, Aubier M, Mentré F, Duval X.

Eur Respir J. 2012 Mar;39(3):772-5. doi: 10.1183/09031936.00113011. No abstract available.

48.

Activity-related dyspnea is not modified by psychological status in people with COPD, interstitial lung disease or obesity.

Sanchez O, Caumont-Prim A, Gillet-Juvin K, Callens E, Graba S, Essalhi M, Chevalier-Bidaud B, Israël-Biet D, Mahut B, Delclaux C.

Respir Physiol Neurobiol. 2012 Jun 15;182(1):18-25. doi: 10.1016/j.resp.2012.02.004. Epub 2012 Feb 17.

PMID:
22366153
49.

The profibrotic cytokine transforming growth factor-β1 increases endothelial progenitor cell angiogenic properties.

Evrard SM, d'Audigier C, Mauge L, Israël-Biet D, Guerin CL, Bieche I, Kovacic JC, Fischer AM, Gaussem P, Smadja DM.

J Thromb Haemost. 2012 Apr;10(4):670-9. doi: 10.1111/j.1538-7836.2012.04644.x.

50.

Roflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide.

Buenestado A, Grassin-Delyle S, Guitard F, Naline E, Faisy C, Israël-Biet D, Sage E, Bellamy JF, Tenor H, Devillier P.

Br J Pharmacol. 2012 Mar;165(6):1877-1890. doi: 10.1111/j.1476-5381.2011.01667.x.

Supplemental Content

Loading ...
Support Center